Chiasm‐compressing rhabdomyosarcoma in a patient presumed to have juvenile‐onset open‐angle glaucoma

Y. Suh,Chungkwon Yoo,Jin-hwan Park,J. Jung,Yong Yeon Kim

DOI: https://doi.org/10.1111/j.1442-9071.2010.02408.x

2011-03-01

Clinical and Experimental Ophthalmology

Abstract:digm of intravitreal anti-VEGF drugs may involve the following: (i) the vasculature of large retinal hemangiomas is mature and may be less dependent upon VEGF for growth or maintenance; (ii) the effective dose required for VHL lesions may be higher than the dose required for the treatment of choroidal neovascularisation; (iii) the route of administration (through the vitreous body) may limit the access to tumour cells in the interior of large endophytic lesions; and (iv) more sustained drug levels may be required for VHL lesions. Actually there are not currently approved therapies for the treatment of VHL-related hemangioblastomas. This is particularly attractive for large RCHs, which are active and at risk for subsequent exuberant exudative detachments after cryotherapy. Thermal ablation of RHC using photocoagulation or cryotherapy currently is the primary therapeutic intervention, but they are burdened by significant side effects, including hemorrhage and exacerbation of exudative retinal detachment; besides multiple treatments might be necessary. The PDT treatment in young patients has been described only in a limited number of reports and in most of them it was used to treat choroidal neovascularisation and choroidal hemangioma in Sturge-Weber syndrome. The PDT, especially at an early stage, may limit vision loss, and is associated with fewer systemic or ocular complications compared to the other treatment options. Therefore verteporfin PDT was chosen as a first-line therapy. The second PDT performed could have been excessive. The increased deposition of hard exudates on the posterior pole could not mean that the RCH was active again. When the RCH stopped leaking after the treatment, there could be an increase of the retinal precipitation of lipoprotein, presumably because early extraction of water and salts from the subretinal fluid increased the concentration of leaked plasma proteins. However, the child was treated again to improve and stable the results. Caution is warranted in drawing conclusions from a single report. However, these data suggest that verteporfin PDT should be considered a possible, very efficient and safe therapeutic option, even in young children with VHLrelated RCHs.